1. HBsAg Kinetics in Retreatment Decision for Off-Therapy Hepatitis B Flare in HBeAg- Negative Patients 
Yun-Fan Liaw, Wen-Juei Jeng, Ming-Ling Chang 
Gastroenterology 
Volume 154, Issue 8, Pages (June 2018)
DOI: /j.gastro
Copyright © 2018 AGA Institute Terms and Conditions

2. Figure 1
The clinical course in 2 hepatitis B e antigen (HBeAg)-negative patients with hepatitis B flare after end of antiviral therapy (EOT). (A) No retreatment is needed in patients with successive HBsAg decline, whereas (B) retreatment is required in patient with increasing HBsAg levels. The horizontal dotted line indicates the upper limit normal of alanine aminotransferase (ALT; 36 U/L).
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2018 AGA Institute Terms and Conditions